SCHEMBL23728610

SCHEMBL23728610

O=C(O)c1ccn2cccc2n1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 2/20 0.66
PTGS2 P35354 2/20 0.66
KDM4E B2RXH2 7/20 0.48
ALOX15 P16050 1/20 0.48
TSHR P16473 1/20 0.48
ACMSD Q8TDX5 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
RAB9A P51151 4/20 0.47
NPC1 O15118 3/20 0.47
MAPT P10636 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
MGAM O43451 1/20 0.40
HPGD P15428 1/20 0.39
GNE Q9Y223 1/20 0.39
TP53 P04637 1/20 0.38
PKM P14618 2/20 0.38
DHODH Q02127 1/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17729288 0.83 PTGS1 (0.50) PTGS1PTGS2KDM4ERAB9ANPC1
SCHEMBL118449 0.79 PTGS1 (1.00) PTGS1PTGS2KDM4ERAB9ANPC1
SCHEMBL2334973 0.78 PTGS1 (0.96) PTGS1PTGS2KDM4ERAB9ANPC1
Water SCHEMBL21708935 0.78 PTGS1 (0.96) PTGS1PTGS2KDM4ERAB9ANPC1
Bromide SCHEMBL570786 0.78 PTGS1 (0.96) PTGS1PTGS2KDM4ERAB9ANPC1
Hydrochloric Acid SCHEMBL8878519 0.78 PTGS1 (0.96) PTGS1PTGS2KDM4ERAB9ANPC1
SCHEMBL22835342 0.74 PTGS1 (0.45) PTGS1PTGS2KDM4EALOX15TSHR
SCHEMBL1815553 0.72 KDM4E (0.47) PTGS1PTGS2KDM4EALOX15TSHR
SCHEMBL1728538 0.68 PTGS1 (0.73) PTGS1PTGS2KDM4ERAB9ANPC1
SCHEMBL23728504 0.68 PTGS1 (0.46) PTGS1PTGS2KDM4EMAPTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4100004-A1 IRAK DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2022-12-14 EP disclosed
WO-2021158634-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2021-08-12 WO disclosed